
Pascal Soriot
Pascal Soriot is the chief executive of AstraZeneca, known for his leadership during the COVID-19 pandemic and his role in the recent cancellation of a significant investment in vaccine production in the UK, citing unmet financial support requirements.
Not in the pool (under ¢1).
Recent news mentions
Pascal Soriot stated that AstraZeneca is recording strong commercial results across all therapeutic areas.
AstraZeneca bilježi rast prodaje i najavljuje ambiciozne cijene do 2030Pascal Soriot is the CEO of AstraZeneca and has emphasized the need for Europe to protect its health sovereignty.
Zdravljenje kroničnih nenalezljivih bolezni zahteva hitre in preventivne ukrepePascal Soriot is the CEO of AstraZeneca who secured a medicine deal with U.S. President Donald Trump.
How AstraZeneca sealed a US medicine deal with TrumpAstraZeneca CEO Pascal Soriot said that during tough negotiations to reach a deal, Trump and his team had 'really kept me up at night'.
AstraZeneca makes deal with Trump to lower drug prices and avoid tariffs | US healthcarePascal Soriot is the global CEO of AstraZeneca and has expressed the company's commitment to investing in China.
【决胜“十四五”】高水平对外开放,提速升级 _光明网AstraZeneca boss Pascal Soriot announced the firm's $50bn investment in the US in July.
AstraZeneca pauses £200m Cambridge investmentPascal Soriot is the CEO of pharmaceutical giant AstraZeneca and earned £14.7 million last fiscal year.
Platy šéfov veľkých britských firiem vzrástli na nový rekord
Pascal Soriot is the CEO of AstraZeneca and has supported Trump's demands regarding drug pricing.
Roche-Präsident Schwan zwischen Trump und Standort SchweizPascal Soriot, the chief executive of AstraZeneca, has emphasized the importance of the US to the company.
AstraZeneca chief executive hails ‘vital importance of US’ as Trump tariffs loom | AstraZenecaThe AstraZeneca chief executive, Pascal Soriot, said the $50bn investment would support the company’s ambition to reach $80bn in revenue by 2030.
AstraZeneca to invest $50bn in US by 2030 amid Trump tariff threats | AstraZenecaPascal Soriot is the CEO of AstraZeneca and emphasizes the need for Europe to protect its health sovereignty.
Vrsta bolezni, zaradi katere umre 41 milijonov ljudi na letoPascal Soriot, the CEO of AstraZeneca, has called on Europe to strengthen its 'health sovereignty'.
Novartis in drugi farmacevtski velikani pozivajo k višjim cenam zdravil v EUAstraZeneca’s chief executive, Pascal Soriot, was also in the audience at a business forum in Beijing.
China needs friends in Trump’s trade war. But Xi may have to go it alone | Global economyPascal Soriot, the CEO of AstraZeneca, expressed commitment to investing in a world-class innovation ecosystem in China.
“硬数据”与“软环境”(望海楼) --观点--人民网Pascal Soriot of AstraZeneca PLC participated in the meeting with Xi Jinping.
Xi meets global business leadersAstraZeneca chief executive Pascal Soriot announced plans for the pharmaceuticals giant to invest $US2.5 billion into a new research and development facility in the Chinese capital.
The Trump turmoil has handed China a golden opportunityPascal Soriot mentioned that AstraZeneca recently announced a $2.5 billion investment plan in China.
看好中国,与中国经济共成长(经济聚焦) --经济·科技--人民网Pascal Soriot from AstraZeneca is participating in the forum with other foreign executives.
Китайський прем'єр закликав до вільної торгівліPascal Soriot, the chief executive of AstraZeneca, stated that the $2.5bn investment reflects their belief in the life sciences ecosystem in Beijing.
AstraZeneca to invest $2.5bn in drugs research and manfacturing in Beijing | AstraZeneca
AstraZeneca’s Pascal Soriot is attending the China Development Forum.
In the Trump era, Europe should shift its gaze towards China – Joseph Stiglitz – The Irish TimesPascal Soriot is the chief executive of AstraZeneca who declared the project in Speke 'absolutely ready to go'.
AstraZeneca, Whitehall, and a failed £450m deal for the next generation in vaccines. What went wrong? | Pharmaceuticals industry







































































